Smith & Nephew CEO walks back medical device layoffs claim

February 11, 2013 by MassDevice staff

Smith & Nephew CEO Olivier Bohuon says recently announced layoffs aren't the result of the medical device tax, despite previous company statements linking the 2.3% levy with the cuts.

Smith & Nephew

Smith & Nephew (FTSE:SN, NYSE:SNN) CEO Olivier Bohuon walked back earlier statements blaming roughly 100 layoffs on the U.S. medical device tax, saying the media got the story wrong.

Last week a Smith & Nephew spokesman told that the job cuts were aimed at offsetting the impact of the tax, a 2.3% levy on all U.S. sales that went into effect Jan. 1 as part of the healthcare reform law.

"The nearly $30 billion tax on medical devices that took effect Jan. 1, 2013, has impacted a number of companies across the U.S.," spokesman Joe Metzger told us. "Smith & Nephew is not immune from this added expense burden."

Sign up to get our free newsletters delivered right to your inbox.

But last week, during a conference call with analysts discussing SNN's Q4 and 2012 results, Bohuon contradicted that statement, saying the media got the story wrong.


Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp